These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 18222252)

  • 1. Does previous percutaneous coronary stenting compromise the long-term efficacy of subsequent coronary artery bypass surgery? A microsimulation study.
    Rao C; Stanbridge Rde L; Chikwe J; Pepper J; Skapinakis P; Aziz O; Darzi A; Athanasiou T
    Ann Thorac Surg; 2008 Feb; 85(2):501-7. PubMed ID: 18222252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of survival after coronary revascularization: modeling short-term, mid-term, and long-term survival.
    MacKenzie TA; Malenka DJ; Olmstead EM; Piper WD; Langner C; Ross CS; O'Connor GT;
    Ann Thorac Surg; 2009 Feb; 87(2):463-72. PubMed ID: 19161761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One-year outcomes of coronary artery bypass graft surgery versus percutaneous coronary intervention with multiple stenting for multisystem disease: a meta-analysis of individual patient data from randomized clinical trials.
    Mercado N; Wijns W; Serruys PW; Sigwart U; Flather MD; Stables RH; O'Neill WW; Rodriguez A; Lemos PA; Hueb WA; Gersh BJ; Booth J; Boersma E
    J Thorac Cardiovasc Surg; 2005 Aug; 130(2):512-9. PubMed ID: 16077421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of coronary revascularization (percutaneous or bypass) in patients with diabetes mellitus and multivessel coronary disease.
    Hee L; Mussap CJ; Yang L; Dignan R; Kadappu KK; Juergens CP; Thomas L; French JK
    Am J Cardiol; 2012 Sep; 110(5):643-8. PubMed ID: 22632829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost effectiveness analysis of minimally invasive internal thoracic artery bypass versus percutaneous revascularisation for isolated lesions of the left anterior descending artery.
    Rao C; Aziz O; Panesar SS; Jones C; Morris S; Darzi A; Athanasiou T
    BMJ; 2007 Mar; 334(7594):621. PubMed ID: 17337457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with 3-vessel or left main coronary artery disease: final results from the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) trial.
    Cohen DJ; Osnabrugge RL; Magnuson EA; Wang K; Li H; Chinnakondepalli K; Pinto D; Abdallah MS; Vilain KA; Morice MC; Dawkins KD; Kappetein AP; Mohr FW; Serruys PW;
    Circulation; 2014 Sep; 130(14):1146-57. PubMed ID: 25085960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of sirolimus-eluting stenting with minimally invasive bypass surgery for stenosis of the left anterior descending coronary artery: 7-year follow-up of a randomized trial.
    Blazek S; Rossbach C; Borger MA; Fuernau G; Desch S; Eitel I; Stiermaier T; Lurz P; Holzhey D; Schuler G; Mohr FW; Thiele H
    JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt A):30-8. PubMed ID: 25499302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing cost aspects of coronary artery bypass graft surgery with coronary artery stenting.
    Birim Ö; Bogers AJ; Kappetein AP
    J Cardiovasc Surg (Torino); 2012 Oct; 53(5):641-50. PubMed ID: 22252542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Provisional stenting for multivessel PCI.
    Han B; Liu L; Aboud M; Nahir M; Hasin Y
    Int J Cardiovasc Intervent; 2005; 7(1):46-51. PubMed ID: 16019615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incomplete revascularization reduces survival benefit of coronary artery bypass grafting: role of off-pump surgery.
    Synnergren MJ; Ekroth R; Odén A; Rexius H; Wiklund L
    J Thorac Cardiovasc Surg; 2008 Jul; 136(1):29-36. PubMed ID: 18603050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of bypass surgery versus stenting in patients with multivessel coronary artery disease.
    Yock CA; Boothroyd DB; Owens DK; Garber AM; Hlatky MA
    Am J Med; 2003 Oct; 115(5):382-9. PubMed ID: 14553874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term clinical outcome of coronary artery stenting or coronary artery bypass grafting in patients with multiple-vessel disease.
    Kohsaka S; Goto M; Virani S; Lee VV; Aoki N; Elayda MA; Reul RM; Wilson JM
    J Thorac Cardiovasc Surg; 2008 Aug; 136(2):500-6. PubMed ID: 18692664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 13-year follow-up of the German angioplasty bypass surgery investigation.
    Kaehler J; Koester R; Billmann W; Schroeder C; Rupprecht HJ; Ischinger T; Jahns R; Vogt A; Lampen M; Hoffmann R; Riessen R; Berger J; Meinertz T; Hamm CW
    Eur Heart J; 2005 Oct; 26(20):2148-53. PubMed ID: 15975991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of coronary artery bypass grafting on specific causes of long-term mortality in the Bypass Angioplasty Revascularization Investigation.
    Holmes DR; Kim LJ; Brooks MM; Kip KE; Schaff HV; Detre KM; Frye RL;
    J Thorac Cardiovasc Surg; 2007 Jul; 134(1):38-46, 46.e1. PubMed ID: 17599484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Projected long-term costs of coronary stenting in multivessel coronary disease based on the experience of the Bypass Angioplasty Revascularization Investigation (BARI).
    Yock CA; Boothroyd DB; Owens DK; Winston C; Hlatky MA
    Am Heart J; 2000 Oct; 140(4):556-64. PubMed ID: 11011328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term follow-up after percutaneous treatment of the unprotected left main stenosis in high risk patients not suitable for bypass surgery.
    Gómez-Hospital JA; Gomez-Lara J; Rondan J; Homs S; Lozano Martínez-Luengas I; Ferreiro JL; Roura G; Maristany J; Teruel L; Carro A; Avanzas P; Jara P; Esplugas E; Moris C; Cequier A
    Rev Esp Cardiol (Engl Ed); 2012 Jun; 65(6):530-7. PubMed ID: 22521483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indications of coronary angioplasty and stenting in 2003: what is left to surgery?
    Poyen V; Silvestri M; Labrunie P; Valeix B
    J Cardiovasc Surg (Torino); 2003 Jun; 44(3):307-12. PubMed ID: 12832982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of the introduction of drug-eluting stents on the clinical practice of surgical and percutaneous treatment of coronary artery disease.
    van Domburg RT; Lemos PA; Takkenberg JJ; Liu TK; van Herwerden LA; Arampatzis CA; Smits PC; Daemen J; Venema AC; Serruys PW; Bogers AJ
    Eur Heart J; 2005 Apr; 26(7):675-81. PubMed ID: 15637087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term clinical outcome after implantation of medium Palmaz (biliary) stents in very large native coronary arteries.
    Chio FL; Liu MW; Al-Saif SM; Khan MA; Lawson D; Al-Mubarak N
    Catheter Cardiovasc Interv; 2002 May; 56(1):35-9. PubMed ID: 11979531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term safety and efficacy of stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: 5-year results from the MAIN-COMPARE (Revascularization for Unprotected Left Main Coronary Artery Stenosis: Comparison of Percutaneous Coronary Angioplasty Versus Surgical Revascularization) registry.
    Park DW; Seung KB; Kim YH; Lee JY; Kim WJ; Kang SJ; Lee SW; Lee CW; Park SW; Yun SC; Gwon HC; Jeong MH; Jang YS; Kim HS; Kim PJ; Seong IW; Park HS; Ahn T; Chae IH; Tahk SJ; Chung WS; Park SJ
    J Am Coll Cardiol; 2010 Jul; 56(2):117-24. PubMed ID: 20451344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.